Clear Crossing Biosciences
PrivateLast Round
Accelerator
May 1, 2024
Company Overview
Clear Crossing Biosciences is a biotechnology company that develops an endosomal release platform for targeted intracellular delivery of RNA therapeutics and therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clear Crossing Biosciences Comparables
Compare Clear Crossing Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Feldan Therapeutics | 82% | |
| Xelcis Bio, Inc. | 82% | |
| Sapreme Technologies BV | 81% |
Clear Crossing Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 1, 2024 |
Key People
Founding team and executive leadership
Clear Crossing Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oregon Bioscience Incubator | Accelerator |
Clear Crossing Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Clear Crossing Biosciences's valuation, stock price, and market status.
Is Clear Crossing Biosciences a public or private company?
Clear Crossing Biosciences is a private company.
What is the current stock price of Clear Crossing Biosciences?
Clear Crossing Biosciences is a private company with no public stock price. Caplight tracks Clear Crossing Biosciences's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Clear Crossing Biosciences worth (valuation)?
Valuation information for Clear Crossing Biosciences is not publicly available.
Can I buy Clear Crossing Biosciences stock?
Clear Crossing Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Clear Crossing Biosciences's last funding round?
Clear Crossing Biosciences's most recent funding round was Accelerator on May 1, 2024.
Who are the main investors in Clear Crossing Biosciences?
Key investors in Clear Crossing Biosciences include Oregon Bioscience Incubator.
Will Clear Crossing Biosciences IPO soon?
No public IPO plans have been announced for Clear Crossing Biosciences.
How can I track Clear Crossing Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clear Crossing Biosciences's secondary market activity and sign up for updates.